List of Studies ( Metabolite:Tyr-Tyr)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004389 | AN007333 | Longitudinal Multi-omics Profiling Reveals Different Adaptation to Heat Stress in Genomically Divergent Lactating Sows | Feces | Pig | Environmental stress | North Carolina State University | LC-MS |
| ST004389 | AN007333 | Longitudinal Multi-omics Profiling Reveals Different Adaptation to Heat Stress in Genomically Divergent Lactating Sows | Milk | Pig | Environmental stress | North Carolina State University | LC-MS |
| ST004350 | AN007261 | The metabolic effects of succinylation and desuccinylation of HADHB at lysine 292 | Cultured cells | Rat | Nanchang University Second Affiliated Hospital | LC-MS | |
| ST004138 | AN006860 | Variation in microbiome and metabolites are associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus | Feces | Human | Autoimmune disease | Hangzhou Xixi Hospital | LC-MS |
| ST004138 | AN006860 | Variation in microbiome and metabolites are associated with advantageous effects of cholestyramine on primary biliary cholangitis with pruritus | Feces | Human | Liver disease | Hangzhou Xixi Hospital | LC-MS |
| ST003911 | AN006421 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 4 | Bacterial cells | Eggerthella lenta | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003911 | AN006421 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 4 | Bacterial cells | Fusobacterium nucleatum | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006418 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Bifidobacteria | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006418 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Clostridium | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006418 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Escherichia coli | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003910 | AN006418 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 3. | Bacterial cells | Streptococcus | Inflammatory bowel disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003880 | AN006373 | Untargeted metabolome analysis of control and disease intervertebral disc tissue | Tissue | Human | Bone disease | Ganga Orthopaedic Research and Education Foundation | LC-MS |
| ST003799 | AN006244 | Molecular fingerprint inference reveals bioactive lipids and microbial metabolites in colitis. Study 2. | Cultured cells | Dorea longicatena | Colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST003768 | AN006186 | The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass | Leaf | Grass | Hunan Agricultural University | LC-MS | |
| ST003768 | AN006186 | The Chromosome-Scale Assembly and Multi-Omics Analysis Reveal Adaptive Evolution and Nitrogen Utilization Mechanisms in Edible Grass | Roots | Grass | Hunan Agricultural University | LC-MS | |
| ST003565 | AN005857 | Metaboloomics analysis of the antimalarial compound WEHI-1888504 (aka compound 59) in Plasmodium falciparum (3D7) infected red blood cells | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003438 | AN005649 | Unbiased genetic screening and metabolomics identifies glial adenosine metabolism as a therapeutic target in Parkinson’s disease | Fly Head | Fruit fly | Parkinsons disease | Broad Institute of MIT and Harvard | LC-MS |
| ST003213 | AN005269 | The central role of creatine and polyamines in fetal growth restriction | Placenta | Human | Placenta disease | University of Udine | LC-MS |
| ST003179 | AN005221 | Property and Activity Refinement of Dihydroquinazolinone-3-carboxamides as Orally Efficacious Antimalarials that Target PfATP4 | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST003172 | AN005206 | Untargeted Metabolomic Profile Of Chili Pepper (Capsicum Chinensed) Developmental Cycle | Capsicum Chinense | Habanero pepper | University of Alberta | LC-MS | |
| ST003036 | AN004977 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 | Bacterial cells | Pseudomonas aeruginosa | Bacterial infection | Monash Institute of Pharmaceutical Sciences | LC-MS |
| ST003024 | AN004958 | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 1 | Bacterial cells | Pseudomonas aeruginosa | Monash Institute of Pharmaceutical Sciences | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides fragilis | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides thetaiotaomicron | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Bacteroides uniformis | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Blautia producta | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium clostridioforme | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hathewayi | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium hylemonae | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium scindens | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Clostridium symbiosum | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecalis | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus faecium | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Enterococcus hirae | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Escherichia fergusonii | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Flavonifractor plautii | Stanford University | LC-MS | |
| ST002832 | AN004625 | Resource competition predicts assembly of in vitro gut bacterial communities- HILIC | Bacterial cells | Parabacteroides distasonis | Stanford University | LC-MS | |
| ST002787 | AN004534 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Feces | Human | Cancer | Wuhan University of Science and Technology | LC-MS |
| ST002759 | AN004479 | Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) | Kidney | Rat | Medical College of Wisconsin | LC-MS | |
| ST002505 | AN004126 | A Mammalian Conserved Circular RNA CircLARP2 Regulates Hepatocellular Carcinoma Metastasis and Lipid Metabolism (Part 1) | Cultured cells | Human | Cancer | University of Science and Technology of China | LC-MS |
| ST002472 | AN004037 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Veillonella parvula cell and media profiling | Bacterial cells | Veillonella parvula | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002471 | AN004033 | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling | Feces | Human | Ulcerative colitis | Broad Institute of MIT and Harvard | LC-MS |
| ST002281 | AN003725 | Metabolite patterns between isogenic normal hiPSCs and Trisomy hiPSC | iPSC cells | Human | Down syndrome | Guangdong Provincial People's Hospital | APCI-MS |
| ST002247 | AN003670 | Microbiota and Health Study (Dhaka, Bangladesh) | Feces | Human | Broad Institute of MIT and Harvard | LC-MS | |
| ST002094 | AN003420 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002094 | AN003421 | Commensal intestinal microbiota regulates host luminal proteolytic activity and intestinal barrier integrity through β-glucuronidase activity (Part 1) | Feces | Human | Irritable bowel syndrome | Mayo Clinic | LC-MS |
| ST002075 | AN003382 | Profiling of the human intestinal microbiome and bile acids under physiologic conditions using an ingestible sampling device (Part 2) | Intestine | Human | University of California, Davis | LC-MS | |
| ST002051 | AN003338 | The apicomplexan parasite Toxoplasma gondii forms bradyzoite-containing tissue cysts that cause chronic and drug-tolerant infections. | Cultured cells | Toxoplasma gondii | Parasitic infection | Robert Koch-Institute | LC-MS |
| ST002028 | AN003298 | Metabolomics Analysis of Blood Plasma and Stool from Six Week Flaxseed Dietary Intervention in Postmenopausal Women (Stool/HILIC) | Feces | Human | University of California, Davis | LC-MS | |
| ST001794 | AN002911 | Metabolomics Analysis of Time-Series Gastrointestinal Lumen Samples | Jejunum | Human | University of California, Davis | LC-MS | |
| ST001205 | AN002007 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001205 | AN002007 | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001204 | AN002004 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Human | Malaria | Monash University | LC-MS |
| ST001204 | AN002004 | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Cultured cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST001175 | AN001951 | Multi-omics analysis demonstrates unique mode of action of a potent new antimalarial compound, JPC-3210, against Plasmodium falciparum | Plasmodium cells | Plasmodium falciparum | Malaria | Monash University | LC-MS |
| ST000974 | AN001595 | GC6-74 matabolomic of TB (Part 1: Plasma) | Blood | Human | Tuberculosis | Max Planck Institute for Infection Biology | LC-MS |
